Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Class A Ordinary Shares, $0.0001 par value per share
-
Shares outstanding
-
15,139,982,333
-
Total 13F shares
-
2,702,089
-
Share change
-
+142,977
-
Total reported value
-
$2,805,684
-
Put/Call ratio
-
110%
-
Price per share
-
$1.04
-
Number of holders
-
28
-
Value change
-
+$189,433
-
Number of buys
-
11
-
Number of sells
-
8
Institutional Holders of TRINITY BIOTECH PLC - Class A Ordinary Shares, $0.0001 par value per share (TRIB) as of Q3 2025
As of 30 Sep 2025,
TRINITY BIOTECH PLC - Class A Ordinary Shares, $0.0001 par value per share (TRIB) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,702,089 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, CAPTRUST FINANCIAL ADVISORS, Moss Adams Wealth Advisors LLC, TWO SIGMA INVESTMENTS, LP, Cambridge Investment Research Advisors, Inc., RAYMOND JAMES FINANCIAL INC, and BECKER CAPITAL MANAGEMENT INC.
This page lists
28
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.